Want to see HK:2509 full AI Analyst Report?
Qyuns Therapeutics Co., Ltd. Class H (2509) Revenue
Qyuns Therapeutics Co., Ltd. Class H Revenue
Qyuns Therapeutics Co., Ltd. Class H had a revenue of 212.03M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 1.02B, Increased 11.88%. In the fiscal year ending Dec 31, 2025, Qyuns Therapeutics Co., Ltd. Class H had annual revenue of 786.08M with 395.03% growth.
- Revenue (ttm)
- 1.02B
- Revenue Growth
- 230.35%
- P/S Ratio
- 4.42
- Revenue/Employee
- HKD 2,332,570
- Employees
- 337
- Market Cap
- HKD 3.47B
Revenue Chart
Qyuns Therapeutics Co., Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 786.08M | 627.28M | 395.03% |
| Dec 31, 2024 | 158.79M | 144.04M | 976.49% |
| Dec 31, 2023 | 14.75M | 5.09M | 52.67% |
| Dec 31, 2022 | 9.66M | -11.69M | -54.74% |
| Dec 31, 2021 | 21.35M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.